Viridian Therapeutics (1S1) Ownership - Who Owns Viridian Therapeutics?
Viridian Therapeutics (1S1) Ownership Overview
- 4.58% Insiders
- 27.95% Mutual Funds
- 0.32% Other Institutional Investors
- 15.55% ETFs
- 51.60% Public Companies and Individual Investors
The ownership structure of Viridian Therapeutics (DE:1S1) stock is a mix of institutional, retail, and individual investors. Approximately 43.82% of the company’s stock is owned by Institutional Investors, 4.58% is owned by Insiders, and 51.60% is owned by Public Companies and Individual Investors.
The ownership structure of Viridian Therapeutics (DE:1S1) stock is a mix of institutional, retail, and individual investors. Approximately 43.82% of the company’s stock is owned by Institutional Investors, 4.58% is owned by Insiders, and 51.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 19, 2026 | Jennifer Tousignant | $348,194 | |
| May 12, 2026 | Fairmount Funds Management Llc | $19,999,990 | |
| Oct 26, 2025 | Fairmount Funds Management Llc | $9,999,990 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Antipodes Partners Ltd | €35,788 | |
| Dec 31, 2025 | Graham Capital Management, L.p. | €772,678 | |
| Dec 31, 2025 | Moore Capital Management Lp | €4,668,000 | |
| Dec 31, 2025 | Driehaus Capital Management Llc | €5,226,106 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 8,551,488 | Institution | 7.55% | 208,493,829 |
| Vanguard | 5,569,499 | Institution | 4.92% | 135,789,955 |
| Fairmount Funds Management Llc | 5,090,928 | Insider | 4.49% | 124,121,916 |
| Peter Harwin | 5,090,928 | Institution | 4.49% | 124,121,916 |
| Vanguard Index Funds | 4,467,394 | Institution | 3.94% | 108,919,533 |
| Ishares | 4,371,165 | Institution | 3.86% | 106,573,374 |
| Fidelity Securities Fund | 3,136,580 | Institution | 2.77% | 76,472,957 |
| Spdr | 2,984,752 | Institution | 2.63% | 72,771,239 |
| Fidelity Select Portfolios | 2,808,304 | Institution | 2.48% | 68,469,260 |
| Fidelity Advisor Series Vii | 2,542,464 | Institution | 2.24% | 61,987,815 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 4,467,394 | Institution | 3.94% | 108,919,533 |
| Fidelity Securities Fund | 3,136,580 | Institution | 2.77% | 76,472,957 |
| Fidelity Select Portfolios | 2,808,304 | Institution | 2.48% | 68,469,260 |
| Fidelity Advisor Series Vii | 2,542,464 | Institution | 2.24% | 61,987,815 |
| Fidelity Concord Street Trust | 2,062,635 | Institution | 1.82% | 50,289,104 |
| T. Rowe Price Health Sciences Fund, Inc. | 1,447,742 | Institution | 1.28% | 35,297,398 |
| Fidelity Rutland Square Trust Ii | 1,404,701 | Institution | 1.24% | 34,248,015 |
| T. Rowe Price New Horizons Fund, Inc. | 1,351,696 | Institution | 1.19% | 32,955,700 |
| Fidelity Salem Street Trust | 1,123,744 | Institution | 0.99% | 27,398,002 |
| Fidelity Capital Trust | 1,089,196 | Institution | 0.96% | 26,555,688 |
FAQ
Who Owns Viridian Therapeutics (DE:1S1)?
According to the latest TipRanks data, approximately 43.82% of the company's stock is held by institutional investors, 4.58% is held by insiders, and 51.60% is held by public companies and individual investors.
What percentage of Viridian Therapeutics (DE:1S1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 43.82% of Viridian Therapeutics (DE:1S1) stock is held by institutional investors: 27.95% by mutual funds, 15.55% by ETFs and 0.32% by other institutional investors.
What percentage of Viridian Therapeutics (DE:1S1) stock is held by retail investors?
According to the latest TipRanks data, approximately 51.60% of Viridian Therapeutics (DE:1S1) stock is held by public companies and individual investors.
Who owns the most shares of Viridian Therapeutics (DE:1S1)?
BlackRock, Inc. owns the most shares of Viridian Therapeutics (DE:1S1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
